PDF herunterladen
Thromb Haemost 2018; 118(12): 2112-2125
DOI: 10.1055/s-0038-1675603
Cellular Haemostasis and Platelets
Georg Thieme Verlag KG Stuttgart · New York

The Inter-Relationship of Platelets with Interleukin-1β-Mediated Inflammation in Humans

Rahajeng N. Tunjungputri
1   Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
2   Center for Tropical and Infectious Diseases (CENTRID), Dr. Kariadi Hospital, Faculty of Medicine, Diponegoro University, Semarang, Indonesia
,
Yang Li
3   Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
,
Philip G. de Groot
1   Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
,
Charles A. Dinarello
1   Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
4   Department of Medicine, University of Colorado Denver–Aurora, Colorado, United States
,
Sanne P. Smeekens
1   Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
,
Martin Jaeger
1   Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
,
Marije Doppenberg-Oosting
1   Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
,
Milou Cruijsen
1   Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
,
Heidi Lemmers
1   Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
,
Helga Toenhake-Dijkstra
1   Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
,
Raul Aguirre-Gamboa
3   Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
,
Vinod Kumar
3   Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
,
Cisca Wijmenga
3   Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
5   Department of Immunology, K. G. Jebsen Coeliac Disease Research Centre, University of Oslo, Oslo, Norway
,
Leo A. B. Joosten
1   Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
6   Department of Medical Genetics, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
,
Mihai G. Netea
1   Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
7   Department for Genomics and Immunoregulation, Life and Medical Sciences Institute (LIMES), University of Bonn, Bonn, Germany
,
Andre van der Ven
1   Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
,
Quirijn de Mast
1   Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
› Institutsangaben Funding The Human Functional Genomics Project is supported by a European Research Council (ERC) Consolidator grant (ERC 310372). R.N.T. is an awardee of the DIKTI-NESO PhD fellowship from the Ministry of Education of Indonesia. C.A.D. is supported by NIH Grant AI-15614. This study was further supported by an IN-CONTROL CVON grant (CVON2012–03) and a Netherlands Organization for Scientific Research (NWO) Spinoza prize (NWO SPI 94–212) to M.G.N; by a an ERC Advanced grant [FP/2007–2013/ERC grant 2012–322698] and an NWO Spinoza prize [NWO SPI 92–266] to C.W.; a European Union Seventh Framework Program grant (EU FP7) TANDEM project [HEALTH-F3–2012–305279] to C.W. and V.K.; and a Research Grant [2017] of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) to V.K.
Weitere Informationen

Publikationsverlauf

07. Juni 2018

22. September 2018

Publikationsdatum:
19. November 2018 (online)

    Lizenzen und Reprints

Abstract

Background Inflammation and coagulation are key processes in cardiovascular diseases (CVDs). The Canakinumab Anti-inflammatory Thrombosis Outcome Study trial affirmed the importance of inflammation in CVD by showing that inhibition of the interleukin (IL)-1β pathway prevents recurrent CVD. A bi-directional relationship exists between inflammation and coagulation, but the precise interaction of platelets and IL-1β-mediated inflammation is incompletely understood. We aimed to determine the inter-relationship between platelets and inflammation—and especially IL-1β—in a cohort of healthy volunteers.

Methods We used data from the 500-Human Functional Genomics cohort, which consists of approximately 500 Caucasian, healthy individuals. We determined associations of plasma levels of IL-1β and other inflammatory proteins with platelet number and reactivity, the association of platelet reactivity with ex vivo cytokine production as well as the impact of genetic variations through a genome-wide association study (GWAS).

Results Platelets were associated with IL-1β on different levels. First, platelet number was positively associated with plasma IL-1β concentrations (p = 8.9 × 10−9) and inversely with concentrations of α-1-anti-trypsin (p = 1.04 × 10−18), which is a known antagonist of IL-1β. Second, platelet degranulation capacity, as determined by agonist-induced P-selectin expression, was associated with ex vivo IL-1β and IL-6 production. Third, several platelet single-nucleotide polymorphisms (SNPs) were associated with cytokine production and there was a significant platelet SNP enrichment in specific biological important pathways. Finally, platelet SNPs were enriched among SNPs earlier identified in GWAS studies in blood-related diseases and immune-mediated diseases.

Conclusion This comprehensive assessment of factors associated with platelet number and reactivity reinforces the important inter-relationship of platelets and IL-1β-mediated inflammation.

Keywords

platelet immunology - inflammation - infectious diseases - cytokines - platelet physiology

Supplementary Material

 

  • References

  • 1 Ridker PM, Everett BM, Thuren T. , et al; CANTOS Trial Group. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med 2017; 377 (12) 1119-1131
    CrossrefPubMedGoogle Scholar
  • 2 Dinarello CA. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 2011; 117 (14) 3720-3732
    CrossrefPubMedGoogle Scholar
  • 3 Libby P. Interleukin-1 beta as a target for atherosclerosis therapy: biological basis of CANTOS and beyond. J Am Coll Cardiol 2017; 70 (18) 2278-2289
    CrossrefPubMedGoogle Scholar
  • 4 Semple JW, Italiano Jr JE, Freedman J. Platelets and the immune continuum. Nat Rev Immunol 2011; 11 (04) 264-274
    CrossrefPubMedGoogle Scholar
  • 5 Davì G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med 2007; 357 (24) 2482-2494
    CrossrefPubMedGoogle Scholar
  • 6 Vieira-de-Abreu A, Campbell RA, Weyrich AS, Zimmerman GA. Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum. Semin Immunopathol 2012; 34 (01) 5-30
    CrossrefPubMedGoogle Scholar
  • 7 Zimmerman GA, Weyrich AS. Signal-dependent protein synthesis by activated platelets: new pathways to altered phenotype and function. Arterioscler Thromb Vasc Biol 2008; 28 (03) s17-s24
    PubMedGoogle Scholar
  • 8 Hottz ED, Lopes JF, Freitas C. , et al. Platelets mediate increased endothelium permeability in dengue through NLRP3-inflammasome activation. Blood 2013; 122 (20) 3405-3414
    CrossrefPubMedGoogle Scholar
  • 9 Lindemann S, Tolley ND, Dixon DA. , et al. Activated platelets mediate inflammatory signaling by regulated interleukin 1β synthesis. J Cell Biol 2001; 154 (03) 485-490
    CrossrefPubMedGoogle Scholar
  • 10 Vinholt PJ, Hvas AM, Frederiksen H, Bathum L, Jørgensen MK, Nybo M. Platelet count is associated with cardiovascular disease, cancer and mortality: a population-based cohort study. Thromb Res 2016; 148: 136-142
    CrossrefPubMedGoogle Scholar
  • 11 Kunicki TJ, Nugent DJ. The genetics of normal platelet reactivity. Blood 2010; 116 (15) 2627-2634
    CrossrefPubMedGoogle Scholar
  • 12 O'Donnell CJ, Larson MG, Feng D. , et al; Framingham Heart Study. Genetic and environmental contributions to platelet aggregation: the Framingham heart study. Circulation 2001; 103 (25) 3051-3056
    CrossrefPubMedGoogle Scholar
  • 13 Crown J, Jakubowski A, Kemeny N. , et al. A phase I trial of recombinant human interleukin-1 beta alone and in combination with myelosuppressive doses of 5-fluorouracil in patients with gastrointestinal cancer. Blood 1991; 78 (06) 1420-1427
    CrossrefPubMedGoogle Scholar
  • 14 Kimura H, Ishibashi T, Shikama Y. , et al. Interleukin-1 beta (IL-1 beta) induces thrombocytosis in mice: possible implication of IL-6. Blood 1990; 76 (12) 2493-2500
    CrossrefPubMedGoogle Scholar
  • 15 Netea MG, Joosten LA, Li Y. , et al. Understanding human immune function using the resources from the Human Functional Genomics Project. Nat Med 2016; 22 (08) 831-833
    CrossrefPubMedGoogle Scholar
  • 16 Ter Horst R, Jaeger M, Smeekens SP. , et al. Host and environmental factors influencing individual human cytokine responses. Cell 2016; 167 (04) 1111-1124.e13
    CrossrefPubMedGoogle Scholar
  • 17 Aguirre-Gamboa R, Joosten I, Urbano PCM. , et al. Differential effects of environmental and genetic factors on T and B cell immune traits. Cell Reports 2016; 17 (09) 2474-2487
    CrossrefPubMedGoogle Scholar
  • 18 Oosting M, Kerstholt M, Ter Horst R. , et al. Functional and genomic architecture of Borrelia burgdorferi-induced cytokine responses in humans. Cell Host Microbe 2016; 20 (06) 822-833
    CrossrefPubMedGoogle Scholar
  • 19 Tunjungputri RN, Van Der Ven AJ, Schonsberg A. , et al. Reduced platelet hyperreactivity and platelet-monocyte aggregation in HIV-infected individuals receiving a raltegravir-based regimen. AIDS 2014; 28 (14) 2091-2096
    CrossrefPubMedGoogle Scholar
  • 20 Snoep JD, Roest M, Barendrecht AD, De Groot PG, Rosendaal FR, Van Der Bom JG. High platelet reactivity is associated with myocardial infarction in premenopausal women: a population-based case-control study. J Thromb Haemost 2010; 8 (05) 906-913
    PubMedGoogle Scholar
  • 21 Tunjungputri RN, van der Ven AJ, Riksen N. , et al. Differential effects of platelets and platelet inhibition by ticagrelor on TLR2- and TLR4-mediated inflammatory responses. Thromb Haemost 2015; 113 (05) 1035-1045
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 22 Consortium GOTN. ; Genome of the Netherlands Consortium. Whole-genome sequence variation, population structure and demographic history of the Dutch population. Nat Genet 2014; 46 (08) 818-825
    CrossrefPubMedGoogle Scholar
  • 23 Deelen P, Bonder MJ, van der Velde KJ. , et al. Genotype harmonizer: automatic strand alignment and format conversion for genotype data integration. BMC Res Notes 2014; 7: 901
    CrossrefPubMedGoogle Scholar
  • 24 Delaneau O, Zagury J-F, Marchini J. Improved whole-chromosome phasing for disease and population genetic studies. Nat Methods 2013; 10 (01) 5-6
    CrossrefPubMedGoogle Scholar
  • 25 Howie B, Marchini J, Stephens M. Genotype imputation with thousands of genomes. G3 (Bethesda) 2011; 1 (06) 457-470
    PubMedGoogle Scholar
  • 26 Deelen P, Menelaou A, van Leeuwen EM. , et al; Genome of Netherlands Consortium. Improved imputation quality of low-frequency and rare variants in European samples using the ‘Genome of The Netherlands’. Eur J Hum Genet 2014; 22 (11) 1321-1326
    PubMedGoogle Scholar
  • 27 Biino G, Santimone I, Minelli C. , et al. Age- and sex-related variations in platelet count in Italy: a proposal of reference ranges based on 40987 subjects' data. PLoS One 2013; 8 (01) e54289
    CrossrefPubMedGoogle Scholar
  • 28 Yeung D, Ciotti S, Purushothama S. , et al. Evaluation of highly sensitive immunoassay technologies for quantitative measurements of sub-pg/mL levels of cytokines in human serum. J Immunol Methods 2016; 437: 53-63
    CrossrefPubMedGoogle Scholar
  • 29 Allam O, Samarani S, Jenabian M-A. , et al. Differential synthesis and release of IL-18 and IL-18 binding protein from human platelets and their implications for HIV infection. Cytokine 2017; 90: 144-154
    CrossrefPubMedGoogle Scholar
  • 30 Banks RE, Forbes MA, Kinsey SE. , et al. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br J Cancer 1998; 77 (06) 956-964
    CrossrefPubMedGoogle Scholar
  • 31 Pott GB, Chan ED, Dinarello CA, Shapiro L. α-1-antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood. J Leukoc Biol 2009; 85 (05) 886-895
    CrossrefPubMedGoogle Scholar
  • 32 Jonigk D, Al-Omari M, Maegel L. , et al. Anti-inflammatory and immunomodulatory properties of α1-antitrypsin without inhibition of elastase. Proc Natl Acad Sci U S A 2013; 110 (37) 15007-15012
    CrossrefPubMedGoogle Scholar
  • 33 Joosten LA, Crişan TO, Azam T. , et al. Alpha-1-anti-trypsin-Fc fusion protein ameliorates gouty arthritis by reducing release and extracellular processing of IL-1β and by the induction of endogenous IL-1Ra. Ann Rheum Dis 2016; 75 (06) 1219-1227
    CrossrefPubMedGoogle Scholar
  • 34 Abecassis A, Schuster R, Shahaf G. , et al. α1-antitrypsin increases interleukin-1 receptor antagonist production during pancreatic islet graft transplantation. Cell Mol Immunol 2014; 11 (04) 377-386
    PubMedGoogle Scholar
  • 35 Jones CI, Bray S, Garner SF. , et al; Bloodomics Consortium. A functional genomics approach reveals novel quantitative trait loci associated with platelet signaling pathways. Blood 2009; 114 (07) 1405-1416
    CrossrefPubMedGoogle Scholar
  • 36 Johnson AD. The genetics of common variation affecting platelet development, function and pharmaceutical targeting. J Thromb Haemost 2011; 9 (Suppl. 01) 246-257
    CrossrefPubMedGoogle Scholar
  • 37 Soranzo N, Spector TD, Mangino M. , et al. A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium. Nat Genet 2009; 41 (11) 1182-1190
    CrossrefPubMedGoogle Scholar
  • 38 Lo KS, Wilson JG, Lange LA. , et al. Genetic association analysis highlights new loci that modulate hematological trait variation in Caucasians and African Americans. Hum Genet 2011; 129 (03) 307-317
    CrossrefPubMedGoogle Scholar
  • 39 Schick UM, Jain D, Hodonsky CJ. , et al. Genome-wide association study of platelet count identifies ancestry-specific loci in Hispanic/Latino Americans. Am J Hum Genet 2016; 98 (02) 229-242
    CrossrefPubMedGoogle Scholar
  • 40 Eicher JD, Chami N, Kacprowski T. , et al; Global Lipids Genetics Consortium; CARDIoGRAM Exome Consortium; Myocardial Infarction Genetics Consortium. Platelet-Related Variants Identified by Exomechip Meta-analysis in 157,293 Individuals. Am J Hum Genet 2016; 99 (01) 40-55
    CrossrefPubMedGoogle Scholar
  • 41 Johnson AD, Yanek LR, Chen M-H. , et al. Genome-wide meta-analyses identifies seven loci associated with platelet aggregation in response to agonists. Nat Genet 2010; 42 (07) 608-613
    CrossrefPubMedGoogle Scholar
  • 42 Geisler T, Schaeffeler E, Gawaz M, Schwab M. Genetic variation of platelet function and pharmacology: an update of current knowledge. Thromb Haemost 2013; 110 (05) 876-887
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 43 Qayyum R, Becker LC, Becker DM. , et al. Genome-wide association study of platelet aggregation in African Americans. BMC Genet 2015; 16: 58
    PubMedGoogle Scholar
  • 44 Faraday N, Yanek LR, Yang XP. , et al. Identification of a specific intronic PEAR1 gene variant associated with greater platelet aggregability and protein expression. Blood 2011; 118 (12) 3367-3375
    CrossrefPubMedGoogle Scholar
  • 45 Meisinger C, Prokisch H, Gieger C. , et al. A genome-wide association study identifies three loci associated with mean platelet volume. Am J Hum Genet 2009; 84 (01) 66-71
    CrossrefPubMedGoogle Scholar
  • 46 van de Veerdonk FL, Netea MG. New insights in the immunobiology of IL-1 family members. Front Immunol 2013; 4: 167
    PubMedGoogle Scholar
  • 47 Li Y, Oosting M, Smeekens SP. , et al. A functional genomics approach to understand variation in vytokine production in humans. Cell 2016; 167 (04) 1099-1110
    CrossrefPubMedGoogle Scholar
  • 48 Welter D, MacArthur J, Morales J. , et al. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res 2014; 42 (Database issue): D1001-D1006
    CrossrefPubMedGoogle Scholar
  • 49 Rondina MT, Weyrich AS, Zimmerman GA. Platelets as cellular effectors of inflammation in vascular diseases. Circ Res 2013; 112 (11) 1506-1519
    CrossrefPubMedGoogle Scholar
  • 50 Beaulieu LM, Lin E, Mick E. , et al. Interleukin 1 receptor 1 and interleukin 1β regulate megakaryocyte maturation, platelet activation, and transcript profile during inflammation in mice and humans. Arterioscler Thromb Vasc Biol 2014; 34 (03) 552-564
    CrossrefPubMedGoogle Scholar
  • 51 Denis MM, Tolley ND, Bunting M. , et al. Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets. Cell 2005; 122 (03) 379-391
    CrossrefPubMedGoogle Scholar
  • 52 Sedlmayr P, Blaschitz A, Wilders-Truschnig M, Tiran A, Dohr G. Platelets contain interleukin-1 alpha and beta which are detectable on the cell surface after activation. Scand J Immunol 1995; 42 (02) 209-214
    Google Scholar
  • 53 Brown GT, Narayanan P, Li W, Silverstein RL, McIntyre TM. Lipopolysaccharide stimulates platelets through an IL-1β autocrine loop. J Immunol 2013; 191 (10) 5196-5203
    CrossrefPubMedGoogle Scholar
  • 54 Shashkin PN, Brown GT, Ghosh A, Marathe GK, McIntyre TM. Lipopolysaccharide is a direct agonist for platelet RNA splicing. J Immunol 2008; 181 (05) 3495-3502
    CrossrefPubMedGoogle Scholar
  • 55 Furman D, Chang J, Lartigue L. , et al. Expression of specific inflammasome gene modules stratifies older individuals into two extreme clinical and immunological states. Nat Med 2017; 23 (02) 174-184
    CrossrefPubMedGoogle Scholar
  • 56 Ghezzi P, Dinarello CA. IL-1 induces IL-1. III. Specific inhibition of IL-1 production by IFN-gamma. J Immunol 1988; 140 (12) 4238-4244
    PubMedGoogle Scholar
  • 57 Dinkla S, van Cranenbroek B, van der Heijden WA. , et al. Platelet microparticles inhibit IL-17 production by regulatory T cells through P-selectin. Blood 2016; 127 (16) 1976-1986
    CrossrefPubMedGoogle Scholar
  • 58 Ando Y, Oku T, Tsuji T. Platelets attenuate production of cytokines and nitric oxide by macrophages in response to bacterial endotoxin. Platelets 2016; 27 (04) 344-350
    CrossrefPubMedGoogle Scholar
  • 59 Weyrich AS, McIntyre TM, McEver RP, Prescott SM, Zimmerman GA. Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-alpha secretion. Signal integration and NF-kappa B translocation. J Clin Invest 1995; 95 (05) 2297-2303
    CrossrefPubMedGoogle Scholar
  • 60 Huang Y, Joshi S, Xiang B. , et al. Arf6 controls platelet spreading and clot retraction via integrin αIIbβ3 trafficking. Blood 2016; 127 (11) 1459-1467
    CrossrefPubMedGoogle Scholar
  • 61 Kim S, Garcia A, Jackson SP, Kunapuli SP. Insulin-like growth factor-1 regulates platelet activation through PI3-Kalpha isoform. Blood 2007; 110 (13) 4206-4213
    CrossrefPubMedGoogle Scholar
  • 62 Wieduwilt MJ, Moasser MM. The epidermal growth factor receptor family: biology driving targeted therapeutics. Cell Mol Life Sci 2008; 65 (10) 1566-1584
    CrossrefPubMedGoogle Scholar
  • 63 Heldin C-H. Targeting the PDGF signaling pathway in tumor treatment. Cell Commun Signal 2013; 11: 97
    CrossrefPubMedGoogle Scholar
  • 64 Petzold T, Ruppert R, Pandey D. , et al. β1 integrin-mediated signals are required for platelet granule secretion and hemostasis in mouse. Blood 2013; 122 (15) 2723-2731
    CrossrefPubMedGoogle Scholar
  • 65 Gasparyan AY, Stavropoulos-Kalinoglou A, Mikhailidis DP, Douglas KM, Kitas GD. Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications. Rheumatol Int 2011; 31 (02) 153-164
    CrossrefPubMedGoogle Scholar
  • 66 Boilard E, Nigrovic PA, Larabee K. , et al. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 2010; 327 (5965): 580-583
    CrossrefPubMedGoogle Scholar
  • 67 Hioki H, Aoki N, Kawano K. , et al. Acute effects of cigarette smoking on platelet-dependent thrombin generation. Eur Heart J 2001; 22 (01) 56-61
    CrossrefPubMedGoogle Scholar
  • 68 Hung J, Lam JY, Lacoste L, Letchacovski G. Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin. Circulation 1995; 92 (09) 2432-2436
    CrossrefPubMedGoogle Scholar
  • 69 Samocha-Bonet D, Justo D, Rogowski O. , et al. Platelet counts and platelet activation markers in obese subjects. Mediators Inflamm 2008; 2008: 834153
    PubMedGoogle Scholar